Literature DB >> 17334365

Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome.

Michael Weber1, Ines Hellmann, Michael B Stadler, Liliana Ramos, Svante Pääbo, Michael Rebhan, Dirk Schübeler.   

Abstract

To gain insight into the function of DNA methylation at cis-regulatory regions and its impact on gene expression, we measured methylation, RNA polymerase occupancy and histone modifications at 16,000 promoters in primary human somatic and germline cells. We find CpG-poor promoters hypermethylated in somatic cells, which does not preclude their activity. This methylation is present in male gametes and results in evolutionary loss of CpG dinucleotides, as measured by divergence between humans and primates. In contrast, strong CpG island promoters are mostly unmethylated, even when inactive. Weak CpG island promoters are distinct, as they are preferential targets for de novo methylation in somatic cells. Notably, most germline-specific genes are methylated in somatic cells, suggesting additional functional selection. These results show that promoter sequence and gene function are major predictors of promoter methylation states. Moreover, we observe that inactive unmethylated CpG island promoters show elevated levels of dimethylation of Lys4 of histone H3, suggesting that this chromatin mark may protect DNA from methylation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17334365     DOI: 10.1038/ng1990

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  918 in total

1.  Methylation profiling using methylated DNA immunoprecipitation and tiling array hybridization.

Authors:  Hoi-Hung Cheung; Tin-Lap Lee; Owen M Rennert; Wai-Yee Chan
Journal:  Methods Mol Biol       Date:  2012

2.  Limiting dilution bisulfite (pyro)sequencing reveals parent-specific methylation patterns in single early mouse embryos and bovine oocytes.

Authors:  Nady El Hajj; Tom Trapphoff; Matthias Linke; Andreas May; Tamara Hansmann; Juliane Kuhtz; Kurt Reifenberg; Julia Heinzmann; Heiner Niemann; Angelika Daser; Ursula Eichenlaub-Ritter; Ulrich Zechner; Thomas Haaf
Journal:  Epigenetics       Date:  2011-10-01       Impact factor: 4.528

3.  DNA methylation in inflammatory genes among children with obstructive sleep apnea.

Authors:  Jinkwan Kim; Rakesh Bhattacharjee; Abdelnaby Khalyfa; Leila Kheirandish-Gozal; Oscar Sans Capdevila; Yang Wang; David Gozal
Journal:  Am J Respir Crit Care Med       Date:  2011-11-10       Impact factor: 21.405

4.  Maternal gametic transmission of translocations or inversions of human chromosome 11p15.5 results in regional DNA hypermethylation and downregulation of CDKN1C expression.

Authors:  Adam C Smith; Masako Suzuki; Reid Thompson; Sanaa Choufani; Michael J Higgins; Idy W Chiu; Jeremy A Squire; John M Greally; Rosanna Weksberg
Journal:  Genomics       Date:  2011-11-03       Impact factor: 5.736

5.  Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells.

Authors:  Yufei Xu; Feizhen Wu; Li Tan; Lingchun Kong; Lijun Xiong; Jie Deng; Andrew J Barbera; Lijuan Zheng; Haikuo Zhang; Stephen Huang; Jinrong Min; Thomas Nicholson; Taiping Chen; Guoliang Xu; Yang Shi; Kun Zhang; Yujiang Geno Shi
Journal:  Mol Cell       Date:  2011-04-21       Impact factor: 17.970

6.  Epigenetic interplay between mouse endogenous retroviruses and host genes.

Authors:  Rita Rebollo; Katharine Miceli-Royer; Ying Zhang; Sharareh Farivar; Liane Gagnier; Dixie L Mager
Journal:  Genome Biol       Date:  2012-10-03       Impact factor: 13.583

Review 7.  A new link between epigenetic progenitor lesions in cancer and the dynamics of signal transduction.

Authors:  Winston Timp; Andre Levchenko; Andrew P Feinberg
Journal:  Cell Cycle       Date:  2009-02-03       Impact factor: 4.534

8.  Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease.

Authors:  Izaskun Villar-Menéndez; Marta Blanch; Shiraz Tyebji; Thais Pereira-Veiga; José Luis Albasanz; Mairena Martín; Isidre Ferrer; Esther Pérez-Navarro; Marta Barrachina
Journal:  Neuromolecular Med       Date:  2013-02-06       Impact factor: 3.843

Review 9.  Epigenomics and breast cancer.

Authors:  Pang-Kuo Lo; Saraswati Sukumar
Journal:  Pharmacogenomics       Date:  2008-12       Impact factor: 2.533

Review 10.  Epigenetics and chromatin dynamics: a review and a paradigm for functional disorders.

Authors:  T Ordog; S A Syed; Y Hayashi; D T Asuzu
Journal:  Neurogastroenterol Motil       Date:  2012-10-24       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.